| Bioactivity | BMS-188107 is a calcium antagonist that exerts anti-ischemic effects. BMS-188107 improves postischemic contractile function and reduces lactate dehydrogenase release. BMS-188107 can be utilized in cardiovascular research[1]. |
| CAS | 139232-80-7 |
| Formula | C25H26N2O4 |
| Molar Mass | 418.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Grover GJ, et al. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim. J Pharmacol Exp Ther. 1993 Oct;267(1):102-7. |
BMS-188107
CAS: 139232-80-7 F: C25H26N2O4 W: 418.48
BMS-188107 is a calcium antagonist that exerts anti-ischemic effects. BMS-188107 improves postischemic contractile funct
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.